Projects

Modulating autophagy and lysosomal pathways to ameliorate cystinosis disease pathology

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2027

Project Lead

Dr. Anil Vasudevan

Authors

Dr. Ravi Manjithaya, Dr. Anil Vasudevan, Dr. Rakesh Mishra Dr. Vasanth Thamodaran

Project Status

ongoing

Project Type

Tata Institute for Genetics and Society